Thrombotic thrombocytopenic purpura: a case report

被引:0
作者
Garcia-Hejl, C. [1 ]
Fagot, T. [2 ]
Foissaud, V. [1 ]
Samson, T. [1 ]
Defuentes, G. [3 ]
Clavier, B. [4 ]
Perez, J. -P. [5 ]
de Revel, T. [2 ]
机构
[1] HIA Percy, Biol Lab, Clamart, France
[2] HIA Percy, Serv Hermatol Clin, Clamart, France
[3] HIA Percy, Serv Med Interne, Clamart, France
[4] HIA Percy, Ctr Transfus Sanguine Armees, Clamart, France
[5] HIA Percy, Serv Anesthesie Reanimat, Clamart, France
关键词
ADAMTS; 13; thrombotic thrombocytopenic purpura; thrombotic microangiopathy;
D O I
10.1684/abc.2008.0206
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We report a case of thrombotic thrombocytopenic purpura (TTP) in a 60 years-old woman with Sjogren's syndrome. Symptomatology on admission leads to evoke the diagnosis of TTP. Biological results allow to set the diagnosis. Actually, association of haemolytic anaemia, schizocytes and thrombocytopenia are in favour of TTP. Undetectable ADAMTS 13 activity (below 5%) confirms the diagnosis. In congenital TTP, plasma ADAMTS 13 is absent or severely reduced as a consequence of mutations in the two ADAMTS 13 gene. In acquired TTP, circulating antibodies inhibit plasma ADAMTS 13 activity. In those cases, further biological studies are needed to find a cause of TTP. Follow-up implies standard laboratory tests. Plasma exchanges are progressively tapered after normalization of platelets count.
引用
收藏
页码:327 / 331
页数:5
相关论文
共 13 条
[1]   Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement [J].
Coppo, P ;
Bengoufa, D ;
Veyradier, A ;
Wolf, M ;
Bussel, A ;
Millot, GA ;
Malot, S ;
Heshmati, F ;
Mira, JP ;
Boulanger, E ;
Galicier, L ;
Durey-Dragon, MA ;
Frémeaux-Bacchi, V ;
Ramakers, M ;
Pruna, A ;
Bordessoule, D ;
Gouilleux, V ;
Scrobohaci, ML ;
Vernant, JP ;
Moreau, D ;
Azoulay, E ;
Schlemmer, B ;
Guillevin, L ;
Lassoued, K .
MEDICINE, 2004, 83 (04) :233-244
[2]  
Coppo P, 2005, REANIM, V14, P594
[3]  
Coppo P, 2005, EMC HEMATOLOGIE, V2, P14
[4]   Time course of organ dysfunction in thrombotic microangiopathy patients receiving either plasma perfusion or plasma exchange [J].
Darmon, Michael ;
Azoulay, Elie ;
Thiery, Guillaume ;
Ciroldi, Magali ;
Galicier, Lionel ;
Parquet, Nathalie ;
Veyradier, Agnes ;
Le Gall, Jean-Roger ;
Oksenhendler, Eric ;
Schlemmer, Benoit .
CRITICAL CARE MEDICINE, 2006, 34 (08) :2127-2133
[5]   Laboratory studies on pathophysiology of the catastrophic antiphospholipid syndrome [J].
Espinosa, Gerard ;
Bucciarelli, Silvia ;
Cervera, Ricard ;
Gomez-Puerta, Jose A. ;
Font, Josep .
AUTOIMMUNITY REVIEWS, 2006, 6 (02) :68-71
[6]   Efficiency of curative and prophylactic treatment with rituximab in ADAMTS 13-deficient thrombotic thrombocytopenic purpura:: a study of 11 cases [J].
Fakhouri, F ;
Vernant, JP ;
Veyradier, A ;
Wolf, M ;
Kaplanski, G ;
Binaut, R ;
Rieger, M ;
Scheiflinger, F ;
Poullin, P ;
Deroure, B ;
Delarue, R ;
Lesavre, P ;
Vanhille, P ;
Hermine, O ;
Remuzzi, G ;
Grünfeld, JP .
BLOOD, 2005, 106 (06) :1932-1937
[7]   Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome [J].
Furlan, M ;
Robles, R ;
Galbusera, M ;
Remuzzi, G ;
Kyrle, PA ;
Brenner, B ;
Krause, M ;
Scharrer, I ;
Aumann, V ;
Mittler, U ;
Solenthaler, M ;
Lämmle, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (22) :1578-1584
[8]   Rituximab prevents recurrence of thrombotic thrombocytopenic purpura:: a case report [J].
Galbusera, M ;
Bresin, E ;
Noris, M ;
Gastoldi, S ;
Belotti, D ;
Capoferri, C ;
Daina, E ;
Perseghin, P ;
Scheiflinger, F ;
Fakhouri, F ;
Grünfeld, JP ;
Pogliani, E ;
Remuzzi, G .
BLOOD, 2005, 106 (03) :925-928
[9]  
Moake Joel L, 2004, Trans Am Clin Climatol Assoc, V115, P201
[10]   The genetics and pathogenesis of haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura [J].
Richards, A ;
Goodship, JA ;
Goodship, THJ .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2002, 11 (04) :431-435